Drugs / NPDR-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07198815 | Dec 2025 → Dec 2026 expected | diabetic retinopathy, retinal microaneurysm | Sichuan Academy of Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPDR-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07198815 ↗ |
| Route | Topical | “NPDR-01 is an investigational ophthalmic solution administered as one drop (50 μL) to the affected eye(s) once daily for a period of 6 months.” NCT07198815 ↗ |